A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial - Concepedia

Concepedia

Publication | Closed Access

A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial

57

Citations

19

References

2007

Year

Daigo Yamamoto, Satoru Iwase, Kaoru Kitamura, Hiroki Odagiri, Chizuko Yamamoto, Yoshinori Nagumo

Cancer Chemotherapy and Pharmacology

Breast OncologyOncologyPathologyPhase Ii StudyBreast CancerCancer TreatmentMedicineRadiation Oncology

References

	Year	Citations

Page 1